UB Paderborn / Katalog / Suche / in CDI

The safety, tolerability, pharmacodynamics, and pharmacokinetics of oral TAK-994 in sleep deprived healthy male subjects

Sleep medicine, 2024-02, Vol.115, p.227-228

2024

Volltextzugriff (PDF)

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (35), p.1-e2207531119

2022

Volltextzugriff (PDF)

Three-dimensional printing technology to create a high-fidelity ureteroscopy simulator: Development and evaluation

European urology, 2021-06, Vol.79, p.S1373-S1374

2021

Volltextzugriff (PDF)

Utilisation de la technologie d’impression 3D pour créer un simulateur haute-fidélité d’urétéroscopie : développement et évaluation

Progrès en urologie (Paris), 2020-11, Vol.30 (13), p.806-807

2020

Volltextzugriff (PDF)

Tips and tricks for image-guided robot-assisted partial nephrectomy

European urology open science (Online), 2020-11, Vol.21, p.S37

2020

Volltextzugriff (PDF)

An accurate tool to inform patients before RAPN: 3D-printed kidney model

European urology open science (Online), 2020-07, Vol.19, p.e1980

2020

Volltextzugriff (PDF)

Improvement of kidney cancer radiological education for medical students with 3D printed patient-specific models

European urology open science (Online), 2020-07, Vol.19, p.e1977

2020

Volltextzugriff (PDF)

Results of a phase 1, 4-period crossover, placebo-controlled, randomized, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-925, a novel orexin 2 receptor agonist, in sleep-deprived healthy adults, utilizing modafinil as an active comparator

Sleep medicine, 2019-12, Vol.64, p.S106-S106

2019

Volltextzugriff (PDF)

A Phase 1 single ascending dose study of a novel orexin 2 receptor agonist, TAK-925, in healthy volunteers (HV) and subjects with narcolepsy type 1 (NT1) to assess safety, tolerability, pharmacokinetics, and pharmacodynamic outcomes

Sleep medicine, 2019-12, Vol.64, p.S105-S106

2019

Volltextzugriff (PDF)

Intérêt de modèles tridimensionnels virtuels et physiques pour évaluation de la complexité tumorale rénale et la planification opératoire des néphrectomies partielles (étude UroCCR-63 : 3D-planning)

Progrès en urologie (Paris), 2019-11, Vol.29 (13), p.757-758

2019

Volltextzugriff (PDF)

La modélisation 3D, un support efficace de l’information-patient avant chirurgie rénale. (Étude UroCCR-39 : Rein-3D-Print)

Progrès en urologie (Paris), 2019-11, Vol.29 (13), p.758-758

2019

Volltextzugriff (PDF)

Anatomical accuracy of 3D-printed patient-specific kidney models used for robot-assisted-partial nephrectomy pre-operative planning (UroCCR study N° 39 : 3D-PRINT)

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1931-e1932

2019

Volltextzugriff (PDF)

PT197 - Anatomical accuracy of 3D-printed patient-specific kidney models used for robot-assisted-partial nephrectomy pre-operative planning (UroCCR study N° 39 : 3D-PRINT)

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1931-e1932

2019

Volltextzugriff (PDF)

Apport de l’impression 3D à la chirurgie rénale mini-invasive : pour l’information préopératoire spécifique – patient et pour l’enseignement de la lecture du scanner–(UroCCR study no 39–3DPRINT)

Progrès en urologie (Paris), 2018-11, Vol.28 (13), p.674-675

2018

Volltextzugriff (PDF)

A Morphological Approach to the Modeling of the Cold Spray Process

Journal of thermal spray technology, 2017-12, Vol.26 (8), p.1838-1850

2017

Volltextzugriff (PDF)

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e520-e520

2017

Volltextzugriff (PDF)

Neo/adjuvant ADT to EBRT: Randomized phase 2 trial of the oral GnRH antagonist, TAK-385 (relugolix, RGX) and degarelix (DGX) in patients (pts) with prostate cancer (PC)

Annals of oncology, 2016-10, Vol.27, p.vi249-vi249

2016

Volltextzugriff (PDF)

Modelling mesoporous alumina microstructure with 3D random models of platelets

Journal of microscopy (Oxford), 2015-12, Vol.260 (3), p.287-301

2015

Volltextzugriff (PDF)

2502 TAK-385, an oral GnRH antagonist: efficacy and safety results from a randomized phase 2 trial in prostate cancer patients (pts)

European journal of cancer (1990), 2015-09, Vol.51, p.S474-S474

2015

Volltextzugriff (PDF)

Direct estimation of austenitic grain dimensions in heat affected zones of a martensitic steel from EBSD images

Journal of microscopy (Oxford), 2015-05, Vol.258 (2), p.87-104

2015

Volltextzugriff (PDF)

Indexing and querying segmented web pages: the BlockWeb Model

World wide web (Bussum), 2011-10, Vol.14 (5-6), p.623-649

2011

Volltextzugriff (PDF)

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

Clinical pharmacokinetics, 2010-12, Vol.49 (12), p.799-816

2010

Volltextzugriff (PDF)

Quantitative Assessment of Exposure-Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

Clinical pharmacology and therapeutics, 2010-03, Vol.87 (3), p.336-344

2010

Volltextzugriff (PDF)

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

European journal of clinical pharmacology, 2008-11, Vol.64 (11), p.1101-1109

2008

Volltextzugriff (PDF)

Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

Clinical pharmacology and therapeutics, 2008-04, Vol.83 (4), p.567-576

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The safety, tolerability, pharmacodynamics, and pharmacokinetics of oral TAK-994 in sleep deprived healthy male subjects

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients

Three-dimensional printing technology to create a high-fidelity ureteroscopy simulator: Development and evaluation

Utilisation de la technologie d’impression 3D pour créer un simulateur haute-fidélité d’urétéroscopie : développement et évaluation

Tips and tricks for image-guided robot-assisted partial nephrectomy

An accurate tool to inform patients before RAPN: 3D-printed kidney model

Improvement of kidney cancer radiological education for medical students with 3D printed patient-specific models

Results of a phase 1, 4-period crossover, placebo-controlled, randomized, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-925, a novel orexin 2 receptor agonist, in sleep-deprived healthy adults, utilizing modafinil as an active comparator

A Phase 1 single ascending dose study of a novel orexin 2 receptor agonist, TAK-925, in healthy volunteers (HV) and subjects with narcolepsy type 1 (NT1) to assess safety, tolerability, pharmacokinetics, and pharmacodynamic outcomes

Intérêt de modèles tridimensionnels virtuels et physiques pour évaluation de la complexité tumorale rénale et la planification opératoire des néphrectomies partielles (étude UroCCR-63 : 3D-planning)

La modélisation 3D, un support efficace de l’information-patient avant chirurgie rénale. (Étude UroCCR-39 : Rein-3D-Print)

Anatomical accuracy of 3D-printed patient-specific kidney models used for robot-assisted-partial nephrectomy pre-operative planning (UroCCR study N° 39 : 3D-PRINT)

PT197 - Anatomical accuracy of 3D-printed patient-specific kidney models used for robot-assisted-partial nephrectomy pre-operative planning (UroCCR study N° 39 : 3D-PRINT)

Apport de l’impression 3D à la chirurgie rénale mini-invasive : pour l’information préopératoire spécifique – patient et pour l’enseignement de la lecture du scanner–(UroCCR study no 39–3DPRINT)

A Morphological Approach to the Modeling of the Cold Spray Process

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Neo/adjuvant ADT to EBRT: Randomized phase 2 trial of the oral GnRH antagonist, TAK-385 (relugolix, RGX) and degarelix (DGX) in patients (pts) with prostate cancer (PC)

Modelling mesoporous alumina microstructure with 3D random models of platelets

2502 TAK-385, an oral GnRH antagonist: efficacy and safety results from a randomized phase 2 trial in prostate cancer patients (pts)

Direct estimation of austenitic grain dimensions in heat affected zones of a martensitic steel from EBSD images

Indexing and querying segmented web pages: the BlockWeb Model

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

Quantitative Assessment of Exposure-Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

Suchergebnisse filtern